Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Biology & Therapy|February 27, 2009
Endothelin-1 inhibits prostate cancer growth in vivo through vasoconstriction of tumor-feeding arteriolesChristine J Weydert, Alison K Esser, Ruth A Mejia, et al.
The Journal of Biological Chemistry|December 11, 2012
Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancerAlison K Esser, Michael R Miller, Qin Huang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 31, 2015
Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor modelAlison K Esser, Anne H Schmieder, Michael H Ross, et al.
Theranostics|July 21, 2020
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast CancerAlison K Esser, Michael H Ross, Francesca Fontana, et al.
Oncotarget|October 21, 2017
HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic miceAlison K Esser, Daniel A Rauch, Jingyu Xiang, et al.
Molecular Cancer Therapeutics|August 14, 2015
CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast CancerJingyu Xiang, Michelle A Hurchla, Francesca Fontana, et al.
JCI Insight|October 4, 2019
HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemiaJingyu Xiang, Daniel A Rauch, Devra D Huey, et al.
Molecular Cancer Therapeutics|March 31, 2021
Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone MetastasesGregory C Fox, Xinming Su, Jennifer L Davis, et al.
Pageof 2